3 Unpopular Stocks That Fall Short

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here are three stocks where the skepticism is well-placed and some better opportunities to consider.

Dine Brands (DIN)

Consensus Price Target: $31.40 (-0.6% implied return)

Operating a franchise model, Dine Brands (NYSE:DIN) is a casual restaurant chain that owns the Applebee’s and IHOP banners.

Why Should You Dump DIN?

1. Disappointing same-store sales over the past two years show customers aren’t responding well to its menu offerings and dining experience
2. Efficiency has decreased over the last year as its operating margin fell by 4.3 percentage points
3. High net-debt-to-EBITDA ratio of 7× could force the company to raise capital at unfavorable terms if market conditions deteriorate

At $31.57 per share, Dine Brands trades at 6.6x forward P/E. Dive into our free research report to see why there are better opportunities than DIN.

DaVita (DVA)

Consensus Price Target: $151.71 (-0.2% implied return)

With over 2,600 dialysis centers across the United States and a presence in 13 countries, DaVita (NYSE:DVA) operates a network of dialysis centers providing treatment and care for patients with chronic kidney disease and end-stage kidney disease.

Why Does DVA Worry Us?

1. Flat treatments over the past two years show it’s struggled to increase its sales volumes and had to rely on price increases
2. Estimated sales growth of 2.5% for the next 12 months implies demand will slow from its two-year trend
3. 1.5 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position

DaVita is trading at $152 per share, or 10.7x forward P/E. If you’re considering DVA for your portfolio, see our FREE research report to learn more.

FTI Consulting (FCN)

Consensus Price Target: $174 (3.8% implied return)

With a team of experts deployed across 30+ countries to tackle complex business challenges, FTI Consulting (NYSE:FCN) is a global business advisory firm that helps organizations manage change, mitigate risk, and resolve disputes across financial, legal, operational, and regulatory matters.

Why Are We Cautious About FCN?

1. Muted 4.2% annual revenue growth over the last two years shows its demand lagged behind its business services peers
2. Earnings growth underperformed the sector average over the last two years as its EPS grew by just 6.8% annually
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 7.9 percentage points

FTI Consulting’s stock price of $167.55 implies a valuation ratio of 18.1x forward P/E. Read our free research report to see why you should think twice about including FCN in your portfolio.

Stocks We Like More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.